Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

Presentation TCT 2025

TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal

Presenter: Mohammed Ebrahim

October 27, 2025

Presentation TCT 2025

TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Presenter: Amer Hussein Muhyieddeen

October 27, 2025

Presentation TCT 2025

TCT 767: Clinical Outcomes of GLP-1 Receptor Agonist Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Presenter: Amer Hussein Muhyieddeen

October 27, 2025

Presentation TCT 2025

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

Presenter: Michael A. Borger

October 27, 2025

Presentation TCT 2025

TCT 760: SGLT2 Inhibitors Reduce Acute Kidney Injury and Improve Survival in Diabetic Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Priyesh Thakurathi

October 27, 2025

Presentation TCT 2025

TCT 763: Finerenone in Patients Undergoing TAVR for Nonrheumatic Aortic Stenosis: Insights from a Real-World Cohort

Presenter: Faysal Massad

October 27, 2025

Presentation TCT 2025

TCT 765: Renin-Angiotensin Inhibition Following TAVR: A Fresh Look at Old Allies — An Updated Meta-Analysis

Presenter: Paulo Roberto Tartuce Filho

October 27, 2025

Presentation TCT 2025

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

Presenter: Ritu Yadav

October 27, 2025

Presentation TCT 2025

TCT 762: Impact of Preoperative Beta-Blockade on Outcomes in Heart Failure Patients Undergoing Surgical Aortic Valve Replacement

Presenter: Hasan Munshi

October 27, 2025

Presentation TCT 2025

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 27, 2025

Presentation TCT 2025

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

Presenter: Frédéric Beaupré

October 27, 2025

Presentation TCT 2025

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Presenter: Gabriela Tirado-Conte

October 27, 2025

Presentation TCT 2025

TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients

Presenter: Noah Tregobov

October 27, 2025

Presentation TCT 2025

TCT 755: Impact of SGLT2 Inhibitors on Outcomes After TAVR: A Real-World Propensity-Matched Analysis

Presenter: Salman Zahid

October 27, 2025

Presentation TCT 2025

TCT 1220: Surgical Aortic Valve Replacement Following TAVR: Long-Term Comparative Outcomes Versus Non-SAVR Cardiac Surgery

Presenter: Osamah Badwan

October 26, 2025

Presentation TCT 2025

TCT 1219: Comparing Valve-in-Valve Versus Redo-Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies: The ViV Procedure Revealed Lower In-Hospital Mortality and Reduced AF Risk Compared to Redo-SAVR

Presenter: Mohammad Reza Movahed

October 26, 2025

Presentation TCT 2025

TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study

Presenter: Shayan Khan

October 26, 2025

Presentation TCT 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Marvin H. Eng

October 26, 2025

Presentation TCT 2025

TCT 873: ALTER Study Results and Preliminary Chinese Single-Center Experience Treating Extra‑Large Aortic Valve Annuli

Presenter: Guangyuan Song

October 26, 2025

Presentation TCT 2025

TCT 1113: Transcatheter versus Surgical Aortic-Valve Replacement in Women with High versus Low Gradient Severe Aortic Stenosis: A Substudy of the RHEIA Trial

Presenter: Philippe Pibarot

October 26, 2025

Advertisement

TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal

TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

TCT 767: Clinical Outcomes of GLP-1 Receptor Agonist Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

TCT 760: SGLT2 Inhibitors Reduce Acute Kidney Injury and Improve Survival in Diabetic Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 763: Finerenone in Patients Undergoing TAVR for Nonrheumatic Aortic Stenosis: Insights from a Real-World Cohort

TCT 765: Renin-Angiotensin Inhibition Following TAVR: A Fresh Look at Old Allies — An Updated Meta-Analysis

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

TCT 762: Impact of Preoperative Beta-Blockade on Outcomes in Heart Failure Patients Undergoing Surgical Aortic Valve Replacement

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients

TCT 755: Impact of SGLT2 Inhibitors on Outcomes After TAVR: A Real-World Propensity-Matched Analysis

TCT 1220: Surgical Aortic Valve Replacement Following TAVR: Long-Term Comparative Outcomes Versus Non-SAVR Cardiac Surgery

TCT 1219: Comparing Valve-in-Valve Versus Redo-Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies: The ViV Procedure Revealed Lower In-Hospital Mortality and Reduced AF Risk Compared to Redo-SAVR

TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

TCT 873: ALTER Study Results and Preliminary Chinese Single-Center Experience Treating Extra‑Large Aortic Valve Annuli

TCT 1113: Transcatheter versus Surgical Aortic-Valve Replacement in Women with High versus Low Gradient Severe Aortic Stenosis: A Substudy of the RHEIA Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content